IMPRINT
Pantarhei Bioscience BV | Boulevard 17 | 3707 BK Zeist | The Netherlands
Phone: +31 (0)30 6 985 020 | Email: info@pantarheibio.com
DISCLAIMER
The information contained in this website is for general information purposes only. The information is provided by Pantarhei Bioscience and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
SOCIAL MEDIA
© 2023
ENDO 2017, April 1-4, 2017 Orlando, USA, Press Release
/in NewsThe first weekend of April, Yvette Zimmerman, COO and Ellen Dutman, CRA at Pantarhei attended the ENDO congress in Orlando, USA, which is organised by the Endocrine Society. The results from a clinical study with estetrol in healthy men were presented in a poster session.
For more information please read the press release of the Endocrine Society. Read more
BioCapital Europe conference March 15, 2017, Amsterdam, the Netherlands
/in NewsThe CEO of Pantarhei, Herjan Coelingh Bennink, will be presenting at the BioCapital Europe Conference on March 15, 2017 in Amsterdam. An ideal opportunity to meet us and discuss possibilities to collaborate, partner with or invest in Pantarhei’s programmes.
17th World Congress of the Academy of Human Reproduction, March 15-18, 2017, Rome, Italy
/in NewsOn Friday March 17, 2017 Pantarhei will sponsor a symposium entitled “Estrogens for the treatment of breast cancer”. Lectures will be presented by Herjan Coelingh Bennink (Results of High Dose Estrogen (HDE) treatment of breast cancer), Richard Santen (Effect of estrogens in preclinical breast cancer models) and Andrea Genazzani (Breast cancer: molecular and hormonal basis of metastasis). The session will be chaired by Piero Sismondi.